Guidance for Eagle Pharmaceuticals (EGRX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2023 | $4.20 – $4.53 | $4.21 | N/A | N/A | = Maintained | Details |
| Q3 2023 | $4.40 – $4.70 | $4.48 | N/A | N/A | = Maintained | Details |
| Q1 2022 | $3.80 – $4.10 | N/A | $120.00M – 130.00M | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
